![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Biogen IDEC - Home - Home - Idec Pharma
Aug 19, 2022 · Paul Chinn leads a Biogen Idec team in groundbreaking cancer research. Read how Paul’s work has helped Rick. Eastern Cooperative Oncology Group (ECOG) Phase III Trial Of Rituxan Maintenance Therapy In Indolent Non-Hodgkin’s Lymphoma Reaches Pre-Specified Efficacy Endpoint Early. Careers. Biogen Idec invests in its employees.
Home | Biogen
Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while advancing a healthier, more sustainable and equitable world.
Biogen - Wikipedia
Biogen was founded in 1978 in Geneva as Biotechnology Geneva by several prominent biologists, including Kenneth Murray from the University of Edinburgh, Phillip Allen Sharp from the Massachusetts Institute of Technology, Walter Gilbert from Harvard University (Gilbert served as CEO during the start-up phase of Biogen), Heinz Schaller from the University of Heidelberg, …
Biogen Inc. (BIIB) Stock Price, News, Quote & History - Yahoo ...
Find the latest Biogen Inc. (BIIB) stock quote, history, news and other vital information to help you with your stock trading and investing.
Biogen Idec Becomes Biogen
Mar 23, 2015 · CAMBRIDGE, Mass.--(BUSINESS WIRE)--Effective today, Biogen Idec is known simply as Biogen (NASDAQ: BIIB). The company has introduced a new corporate identity and logo that reflect both its evolution and focus on bringing forth new therapies in areas of high unmet need – while honoring Biogen’s scientific heritage and legacy as a pioneer in ...
Biogen and IDEC Pharmaceuticals Announce Merger To Create a ...
Aug 18, 2022 · BIOGEN IDEC will be headquartered in Cambridge, MA and will maintain centers of excellence in San Diego and Cambridge focused, respectively, on oncology and immunology. In addition, BIOGEN IDEC will have international operations in …
Company Overview - Idec Pharma
Aug 18, 2022 · Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing and commercialization of innovative therapies. Patients in more than 90 countries benefit from Biogen Idec’s significant products that address diseases such as multiple sclerosis (MS), lymphoma and rheumatoid arthritis.
Biogen Idec Becomes Biogen | Fierce Pharma
Mar 23, 2015 · Through cutting-edge science and medicine, Biogen discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hematologic ...